GENB · Director Frances Arnold filed a Form 144 notice to sell 11,409 shares…

Director Frances Arnold filed a Form 144 notice to sell 11,409 shares of Generate Biomedicines common stock, valued at approximately $184,733 based on the filing date price. The shares were acquired via restricted stock vesting on September 23, 2020, as compensation. This is an advance notice of intent to sell, not a completed transaction, and the sale may not occur.

• Reporting owner: Frances Arnold, a Director of Generate Biomedicines, Inc.
• Proposed sale of 11,409 shares of common stock.
• Estimated aggregate market value: $184,732.91.
• Shares acquired on 09/23/2020 via restricted stock vesting as compensation.